Inventor
MESSINA DARIN J
US32 patents
⚠️ This page may combine multiple inventors who share the name “MESSINA DARIN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DEPUY SYNTHES PRODUCTS INC
7 patentsUS10220059B2Mar 5, 2019
Postpartum cells derived from placental tissue, and methods of making and using the same
DEPUY SYNTHES PRODUCTS INC5 citations84
US11000554B2May 11, 2021
Postpartum cells derived from placental tissue, and methods of making and using the same
DEPUY SYNTHES PRODUCTS INC0 citations73
US10195233B2Feb 5, 2019
Postpartum cells derived from placental tissue, and methods of making and using the same
DEPUY SYNTHES PRODUCTS INC1 citations73
US10500234B2Dec 10, 2019
Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
DEPUY SYNTHES PRODUCTS INC0 citations63
US10383898B2Aug 20, 2019
Postpartum cells derived from placental tissue, and methods of making and using the same
DEPUY SYNTHES PRODUCTS INC0 citations63
US10744164B2Aug 18, 2020
Repair and regeneration of ocular tissue using postpartum-derived cells
DEPUY SYNTHES PRODUCTS INC0 citations52
US9572840B2Feb 21, 2017
Regeneration and repair of neural tissue using postpartum-derived cells
DEPUY SYNTHES PRODUCTS INC0 citations42
ETHICON INC
6 patentsUS7560276B2Jul 14, 2009
Soft tissue repair and regeneration using postpartum-derived cells
ETHICON INC96 citations99
US7524489B2Apr 28, 2009
Regeneration and repair of neural tissue using postpartum-derived cells
ETHICON INC87 citations99
US7510873B2Mar 31, 2009
Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same
ETHICON INC131 citations99
US7413734B2Aug 19, 2008
Treatment of retinitis pigmentosa with human umbilical cord cells
ETHICON INC223 citations99
US7875272B2Jan 25, 2011
Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
ETHICON INC82 citations96
US7875273B2Jan 25, 2011
Treatment of Parkinson's disease and related disorders using postpartum derived cells
ETHICON INC91 citations95
ALLERGAN INC
5 patentsUS9662422B2May 30, 2017
Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
ALLERGAN INC17 citations90
US10300169B2May 28, 2019
Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
ALLERGAN INC5 citations81
US10744227B2Aug 18, 2020
Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
ALLERGAN INC2 citations70
US11844878B2Dec 19, 2023
Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
ALLERGAN INC0 citations60
US9782517B2Oct 10, 2017
Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
ALLERGAN INC1 citations60
MISTRY SANJAY
3 patentsUS8318483B2Nov 27, 2012
Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
MISTRY SANJAY44 citations98
US9498501B2Nov 22, 2016
Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
MISTRY SANJAY16 citations95
US8846394B2Sep 30, 2014
Treatment of neurological deficits in the striatum or substanta nigra pars compacta
MISTRY SANJAY1 citations51